- Home
- SPRC vs SLRX Comparison
SPRC vs SLRX Comparison
Compare SPRC & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRC
- SLRX
- Stock Information
- Founded
- SPRC 2004
- SLRX N/A
- Country
- SPRC Israel
- SLRX United States
- Employees
- SPRC N/A
- SLRX N/A
- Industry
- SPRC Biotechnology: Pharmaceutical Preparations
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- SPRC Health Care
- SLRX Health Care
- Exchange
- SPRC Nasdaq
- SLRX Nasdaq
- Market Cap
- SPRC 1.2M
- SLRX 1.4M
- IPO Year
- SPRC N/A
- SLRX N/A
- Fundamental
- Price
- SPRC $0.31
- SLRX $1.57
- Analyst Decision
- SPRC
- SLRX
- Analyst Count
- SPRC 0
- SLRX 0
- Target Price
- SPRC N/A
- SLRX N/A
- AVG Volume (30 Days)
- SPRC 2.8M
- SLRX 109.5K
- Earning Date
- SPRC 09-27-2024
- SLRX 11-07-2024
- Dividend Yield
- SPRC N/A
- SLRX N/A
- EPS Growth
- SPRC N/A
- SLRX N/A
- EPS
- SPRC N/A
- SLRX N/A
- Revenue
- SPRC $2,879,000.00
- SLRX N/A
- Revenue This Year
- SPRC N/A
- SLRX N/A
- Revenue Next Year
- SPRC N/A
- SLRX N/A
- P/E Ratio
- SPRC N/A
- SLRX N/A
- Revenue Growth
- SPRC 113.73
- SLRX N/A
- 52 Week Low
- SPRC $0.28
- SLRX $1.35
- 52 Week High
- SPRC $14.22
- SLRX $7.60
- Technical
- Relative Strength Index (RSI)
- SPRC 38.57
- SLRX 42.52
- Support Level
- SPRC $0.28
- SLRX $1.43
- Resistance Level
- SPRC $0.32
- SLRX $1.68
- Average True Range (ATR)
- SPRC 0.03
- SLRX 0.12
- MACD
- SPRC 0.00
- SLRX 0.02
- Stochastic Oscillator
- SPRC 20.67
- SLRX 27.66
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.